Published in Gene Therapy Weekly, January 6th, 2005
The licensing agreement gives Nanomix the right to use and further develop the technology, invented by Dr. George Gruner of UCLA. Future applications of this promising technology may range from glucose monitoring to viral and infectious disease detection and even homeland security.
"We are very excited to be licensing partners with UCLA, helping to advance our biomolecule detection platform," said David Macdonald, CEO and president of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.